Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 2
2014 11
2015 21
2016 18
2017 23
2018 20
2019 16
2020 15
2021 12
2022 8
2023 10
2024 6
2025 6
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

146 results

Results by year

Filters applied: . Clear all
Page 1
Evaluating naloxegol for the treatment of opioid-induced constipation.
Daniali M, Nikfar S, Abdollahi M. Daniali M, et al. Expert Opin Pharmacother. 2020 Jun;21(8):883-891. doi: 10.1080/14656566.2020.1735354. Epub 2020 Mar 4. Expert Opin Pharmacother. 2020. PMID: 32129103 Review.
INTRODUCTION: Due to the increased use of opioids for pain and their abuse globally, the rate of restrictive side effects is elevating. Opioid-induced constipation (OIC) is probably the most widespread, underdiagnosed, and yet common adverse effect. ...AREAS …
INTRODUCTION: Due to the increased use of opioids for pain and their abuse globally, the rate of restrictive side effects is elevating. O …
Management of opioid-induced constipation.
Prichard D, Norton C, Bharucha AE. Prichard D, et al. Br J Nurs. 2016 May 26-Jun 8;25(10):S4-5, S8-11. doi: 10.12968/bjon.2016.25.10.S4. Br J Nurs. 2016. PMID: 27231750 Free article. Review.
Up to 40% of patients taking opioids develop constipation. Opioid-induced constipation (OIC) may limit the adequate dosing of opioids for pain relief and reduce quality of life. ...Lifestyle modification and alteration of aggravating factors, the use o …
Up to 40% of patients taking opioids develop constipation. Opioid-induced constipation (OIC) may limit the adequ …
Naloxegol for the treatment of opioid-induced constipation.
Tack J, Corsetti M. Tack J, et al. Expert Rev Gastroenterol Hepatol. 2014 Nov;8(8):855-61. doi: 10.1586/17474124.2014.939629. Epub 2014 Sep 15. Expert Rev Gastroenterol Hepatol. 2014. PMID: 25220391 Review.
With increasing chronic opioid use, opioid-induced constipation (OIC) is a rapidly increasing clinical challenge. Naloxegol, an orally administered, peripherally-acting, -opioid receptor antagonist, was developed for the treatment of OIC …
With increasing chronic opioid use, opioid-induced constipation (OIC) is a rapidly increasing clinical challenge …
Naloxegol: Therapeutic area: Management of opioid-induced constipation: Reimbursement Review.
[No authors listed] [No authors listed] Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2025 Jul. Report No.: SX0753r. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2025 Jul. Report No.: SX0753r. PMID: 40857365 Free Books & Documents. Review.
WHAT IS OPIOID-INDUCED CONSTIPATION? Opioid-induced constipation (OIC) is constipation that is triggered or aggravated by opioid therapy taken for pain control. ...WHAT ARE THE TREATMENT GOALS AND CURRENT TREATMENT OPTIONS …
WHAT IS OPIOID-INDUCED CONSTIPATION? Opioid-induced constipation (OIC) is constipation th …
Naloxegol: treatment for opioid-induced constipation in chronic non-cancer pain.
Leonard J, Baker DE. Leonard J, et al. Ann Pharmacother. 2015 Mar;49(3):360-5. doi: 10.1177/1060028014560191. Epub 2014 Dec 3. Ann Pharmacother. 2015. PMID: 25471070 Review.
OBJECTIVE: To describe the effectiveness of naloxegol for the treatment of opioid-induced constipation (OIC) in chronic non-cancer pain patients. ...This entailed a mean increase in SBMs, at least 3 SBMs per week, efficacy in 9 of 12 weeks, and efficac …
OBJECTIVE: To describe the effectiveness of naloxegol for the treatment of opioid-induced constipation (OIC) in …
Naloxegol for Treatment of Opioid-Induced Constipation in the Pediatric Intensive Care Unit.
Gillett EL, Layes CA, Crawley L, Schexnayder SM. Gillett EL, et al. Clin Pediatr (Phila). 2023 Jul;62(7):721-724. doi: 10.1177/00099228221142129. Epub 2022 Dec 7. Clin Pediatr (Phila). 2023. PMID: 36475875
Opioid-induced constipation is a common problem in critically ill children requiring sedation. Naloxegol is an oral U.S. Food and Drug Administration (FDA)-approved peripherally acting mu-opioid receptor antagonist for chronic opioid-i …
Opioid-induced constipation is a common problem in critically ill children requiring sedation. Naloxegol is an o …
Naloxegol versus Methylnaltrexone for Opioid-Induced Constipation in Critically Ill Patients.
Tobben D, Carpenter S, Kolar R, Merritt T, Young T, Hauser P, Collier T. Tobben D, et al. Ann Pharmacother. 2024 Jul;58(7):678-684. doi: 10.1177/10600280231205023. Epub 2023 Oct 26. Ann Pharmacother. 2024. PMID: 37881915
BACKGROUND: Constipation impacts 58% to 83% of critically ill patients and is associated with increased time on mechanical ventilation, delirium, and increased length of stay (LOS) in the intensive care unit (ICU). OBJECTIVE: The purpose of this study was to evaluate the e …
BACKGROUND: Constipation impacts 58% to 83% of critically ill patients and is associated with increased time on mechanical ventilatio …
Naloxegol for opioid-induced constipation.
[No authors listed] [No authors listed] Drug Ther Bull. 2015 Dec;53(12):138-40. doi: 10.1136/dtb.2015.12.0369. Drug Ther Bull. 2015. PMID: 26660436 Review.
Naloxegol (Moventig-AstraZeneca) is a peripherally acting mu-opioid receptor antagonist licensed for the treatment of opioid-induced constipation in adults who have had an inadequate response to laxative treatment. It was launched in the United …
Naloxegol (Moventig-AstraZeneca) is a peripherally acting mu-opioid receptor antagonist licensed for the treatment of opio …
A Systematic Review of Naldemedine and Naloxegol for the Treatment of Opioid-Induced Constipation in Cancer Patients.
Braun UK, Jackson LK, Garcia MA, Imam SN. Braun UK, et al. Pharmacy (Basel). 2024 Mar 6;12(2):48. doi: 10.3390/pharmacy12020048. Pharmacy (Basel). 2024. PMID: 38525728 Free PMC article. Review.
BACKGROUND: Opioid-induced constipation (OIC) is a pervasive and distressing side effect of chronic opioid therapy in patients with cancer pain, significantly impacting their quality of life. ...For naloxegol, only two randomized controlled tria …
BACKGROUND: Opioid-induced constipation (OIC) is a pervasive and distressing side effect of chronic opioid thera …
146 results